Morgan Stanley Private Equity Asia Overview
- Investor Type
-
PE/Buyout
- Status
-
Active
- Professionals
-
13
- Investments
-
144
- Portfolio
-
46
- Exits
-
94
Morgan Stanley Private Equity Asia General Information
Company Description
Founded in 1993, Morgan Stanley Private Equity Asia is a private equity arm of the Morgan Stanley Investment Management firm based in New York. The firm seeks to invest in companies operating in the consumer products, industrial products, financial services, healthcare, telecom, and technology sectors.
Business Details
Year Founded
Investor Status
Primary Investor Type
Other Investor Types
Corporate Office
- 1585 Broadway
- New York, NY 10036
- United States
Morgan Stanley Private Equity Asia Investments (144)
Morgan Stanley Private Equity Asia’s most recent investment was a with Cytecare Hospitals. The deal was made on 05-Nov-2025 with as the lead partner.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Cytecare Hospitals | 05-Nov-2025 | Hospitals/Inpatient Services | Profitable | |||
| Anant Raj | 13-Oct-2025 | Infrastructure | Profitable | |||
| Jiomax Hospital | 14-May-2025 | Hospitals/Inpatient Services | Generating Revenue | |||
| Gujarat Pathology Laboratory & Diagnostic Center | 16-Apr-2025 | Laboratory Services (Healthcare) | Generating Revenue | |||
| Dr Agarwals Healthcare | 28-Jan-2025 | PE Growth/Expansion | Hospitals/Inpatient Services | Profitable |
Morgan Stanley Private Equity Asia Exits (94)
Morgan Stanley Private Equity Asia has made a total of 94 exits. Its latest exit was from Sahajanand Medical Technologies for on 23-Oct-2026. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Sahajanand Medical Technologies | 23-Oct-2026 | ||
| Southern Health Foods | 09-Feb-2026 | ||
| Omni Devices | 24-Jun-2025 | ||
| Korres Natural Products | 28-Apr-2025 | ||
| Monalisa | 04-Nov-2024 | Merger/Acquisition |
Morgan Stanley Private Equity Asia Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
Morgan Stanley Private Equity Asia Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Morgan Stanley Private Equity Asia FAQs
-
What is Morgan Stanley Private Equity Asia?
Founded in 1993, Morgan Stanley Private Equity Asia is a private equity arm of the Morgan Stanley Investment Management firm based in New York.
-
When was Morgan Stanley Private Equity Asia founded?
Morgan Stanley Private Equity Asia was founded in 1993.
-
Where is Morgan Stanley Private Equity Asia headquartered?
Morgan Stanley Private Equity Asia is headquartered in New York, NY.
-
What is Morgan Stanley Private Equity Asia's total asset value?
Morgan Stanley Private Equity Asia has around in total assets under management.
-
How many investments has Morgan Stanley Private Equity Asia made?
Morgan Stanley Private Equity Asia has made 144 investments.
-
What has Morgan Stanley Private Equity Asia invested in?
Morgan Stanley Private Equity Asia has made numerous investments in companies like Cytecare Hospitals, Anant Raj, and Jiomax Hospital within the Hospitals/Inpatient Services and Infrastructure industries.
-
What has Morgan Stanley Private Equity Asia invested in recently?
Morgan Stanley Private Equity Asia's latest investment was on 05-Nov-2025 in Cytecare Hospitals, a company within the Hospitals/Inpatient Services industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
